Publication: Comparison of atrial septal defect closure using amplatzer septal occluder with surgery
Issued Date
2002-01-01
Resource Type
ISSN
01720643
Other identifier(s)
2-s2.0-0036372795
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Pediatric Cardiology. Vol.23, No.1 (2002), 36-40
Suggested Citation
K. Durongpisitkul, J. Soongswang, D. Laohaprasitiporn, A. Nana, S. Sriyoschati, S. Ponvilawan, T. Subtaweesin, C. Kangkagate Comparison of atrial septal defect closure using amplatzer septal occluder with surgery. Pediatric Cardiology. Vol.23, No.1 (2002), 36-40. doi:10.1007/s00246-001-0010-6 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/20565
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Comparison of atrial septal defect closure using amplatzer septal occluder with surgery
Other Contributor(s)
Abstract
Our study reports the results of a comparison of closure of atrial septal defect (ASD) surgically with transcatheter closure using the Amplatzer septal occluder. Patients having an ASD and a surgical closure or transcatheter closure between January 1999 and July 2000 were selected. There were 103 patients who had ASD. All 64 patients in group 1 (surgery) had a successful operation, with only 2 patients with a mild residual shunt. There were 39 patients enrolled for transcatheter closure of the ASD (group 2). Four patients were excluded initially. The median age for group 1 was 25 years (range 2.3-64 years) compared to 11.7 years (range 2-69 years) in group 2 (p = 0.035). In group 1, the mean ASD diameter measured was 28.4 ± 10.2 mm compared to 23.4 ± 5.7 mm in group 2 (p = 0.003). In 29 patients, devices were deployed with sizes from 10 mm to 30 mm (median 24 mm). Three patients were excluded because a larger device (>30 mm) was not available and devices were not successfully deployed in another 3 patients. One patient had a device embolized into the right ventricle (surgical removal and closure of the ASD). Complications occurred in 13 patients in group 1 and 4 patients in group 2. Complete occlusion occurred in 27 of 28 group 2 patients (96.4%) during the follow-up period (10.2 ± 5.4 months). The Amplatzer septal occluder is a new device for closure of different-sized ASDs. The intermediate-term follow-up demonstrated excellent closure results. The benefit for each patient was demonstrated in less morbidity and less time spent in the hospital.